January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 07, 2026
Based on market forecasts, the western blotting sector will expand from USD 2.13 billion in 2025 to USD 3.84 billion by 2035, experiencing a CAGR of 6.05%. The increasing prevalence of chronic disorders and technological advancements drive the market. North America dominated the global market owing to the presence of key players and increasing rese...
January 06, 2026
According to market projections, the liquid biopsy sector is expected to grow from USD 7.08 billion in 2025 to USD 27.42 billion by 2035, reflecting a CAGR of 14.5%, driven by the need for non-invasive cancer diagnostics. It enables real-time monitoring, early detection, and personalized treatment. Advances in NGS, ctDNA analysis, and AI are enhanc...
January 06, 2026
Market insights predict, the U.S. next generation sequencing industry is expected to grow from USD 2.85 billion in 2025 to USD 12.52 billion by 2035, driven by a CAGR of 15.95%. The growing demand for personalized medicines and the increasing adoption of advanced technologies drive the market....
January 02, 2026
Projections indicate that, the global plasmid DNA manufacturing market will increase from USD 2.61 billion in 2025 to USD 14.59 billion by 2035, experiencing a CAGR of 18.77% over the next 10 years. Plasmid DNA is highly valuable in conducting research, studying diseases, studying gene mutations, repairing genetic material, and developing GMOs for ...
December 31, 2025
Market insights predict, the sequencing industry is expected to grow from USD 23.28 billion in 2025 to USD 173 billion by 2035, driven by a CAGR of 22.21%. The market is witnessing rapid growth due to increased applications in different industries....
December 30, 2025
The biopharmaceuticals market size is calculated at $ 474.28 bn in 2025 is to hit $1540.14 bn by 2035. The biopharmaceuticals market is growing rapidly, driven by advances in biologics, personalized medicine, and gene therapy. Innovations in monoclonal antibodies, vaccines, and cell therapies are transforming treatments. Demand for biologics in chr...
December 30, 2025
According to market projections, the microRNA market will increase from $2.05 billion in 2025 to $6.89 billion by 2035, including the dominant market share held by North America at 41.6% in 2025 and the rapidly expanding Asia Pacific region, which is expected to grow at the fastest rate during the forecast period....
December 30, 2025
Market insights predict the global cell harvesting industry will increase from USD 6.71 billion in 2025 to USD 22.68 billion by 2035, achieving a CAGR of 12.95%. The cell harvesting market is expanding due to rising demand for cell and gene therapies as well as growing use of stem cell-based treatment approaches. North America led the market due to...
December 30, 2025
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance of DNA methylation. North America dominated the market in 2024 owing to the robust research and deve...
December 30, 2025
According to market projections, the RNA analysis sector is expected to grow from USD 6.86 billion in 2025 to USD 23.9 billion by 2035, reflecting a CAGR of 13.36%. The RNA analysis market is growing due to increasing demand for personalized medicine. North America is leading due to its advanced research infrastructure and favorable government envi...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com